Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone. Study Design: Using US health ...
Sept. 19, 2003 -- Continuous combined hormone therapy may be appropriate for women with endometriosis pain not controlled by cyclic therapy, according to the results of a prospective, self-controlled ...
Researchers confirmed that a daily, combined dose of estrogen and progestin increases breast cancer risk in post menopausal women, but added that this risk begins to return to normal about six months ...
WALTHAM, Mass.--(BUSINESS WIRE)--Glytec, the only provider of insulin management software across the continuum of care, today published the first proof-of-concept study that combines data from ...
Several contemporary formulations of hormone therapy administered during the menopausal transition carry some degree of cardiovascular risk, Swedish registry data affirm. Most consistent was an ...
IT is sometimes desired to illuminate an object in an optical system at one level for general examination and at a momentarily higher level for photographic recording. The development of a combined ...
CLEVELAND, Ohio (June 24, 2020)--Women with premature ovarian insufficiency (POI) become estrogen deficient at an early age, which makes them more vulnerable to the loss of bone mineral density. A new ...
Women with premature ovarian insufficiency (POI) become estrogen deficient at an early age, which makes them more vulnerable to the loss of bone mineral density. A new study suggests that the use of ...
A phase II trial of the Src kinase inhibitor AZD0530 in patients with metastatic or locally advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: A trial of the PMH phase II consortium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback